Lyell Immunopharma, Inc. (NASDAQ:LYEL – Get Free Report) traded up 6.6% on Monday . The stock traded as high as $2.03 and last traded at $2.03. 740,615 shares traded hands during mid-day trading, a decline of 46% from the average session volume of 1,368,029 shares. The stock had previously closed at $1.90. Wall Street Analysts […]
Iovance: Approval For Solid Tumor Targeting TIL Therapy Likely, Outlook Promising (IOVA) seekingalpha.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from seekingalpha.com Daily Mail and Mail on Sunday newspapers.
Iovance s IOVA stock price suffers a harsh reversal: buy the dip? invezz.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from invezz.com Daily Mail and Mail on Sunday newspapers.
TD Asset Management Inc grew its position in shares of Lyell Immunopharma, Inc. (NASDAQ:LYEL – Free Report) by 140.4% during the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 431,916 shares of the company’s stock after purchasing an additional 252,227 shares during the quarter. TD […]
Apart from the already existing players such as Pfizer, Sanofi, Taiho Pharma, Ono Pharma, along with others, there are several emerging key players, that are.